GizmagBlood test uses human stem cells to predict severe drug reactionsGizmagScientists have developed a blood test using human stem cells that predicts whether new drugs will cause severe side effects. The test, which only requires blood from a single… Continue reading
GizmagBlood test uses human stem cells to predict severe drug reactionsGizmagScientists have developed a blood test using human stem cells that predicts whether new drugs will cause severe side effects. The test, which only requires blood from a single… Continue reading
|
Researchers discover genetic origins of myelodysplastic syndrome using stem …
Phys.Org Induced pluripotent stem cells (iPSCs)—adult cells reprogrammed back to an embryonic stem cell-like state—may better model the genetic contributions to each patient’s particular disease. In a process called cellular reprogramming, researchers at … Public Release: 25-Mar-2015 Researchers discover genetic origins of …EurekAlert (press release) Mount Sinai Researchers Discover Genetic Origins of Myelodysplastic …Newswise (press release) |
Channel News Asia |
BioLineRX stem cell leukemia drug meets goals in early trial
Yahoo News Current stem cell treatments require four or five days of injections of material from a donor to get into the bloodstream, but BioLineRX said its treatment, currently called BL-8040, needed just one. “The results support BL-8040 as a one-day, single … BioLineRx Reports Successful Top-Line Safety and Efficacy Results for Novel …PharmiWeb.com (press release) |
CBC.ca |
Ebola pioneer, stem cell researcher honoured with Canada Gairdner Awards
CBC.ca One of the co-discoverers of the Ebola virus and a leading Canadian stem cell researcher are among this year’s winners of the prestigious Canada Gairdner Awards. Dr. Peter Piot is the recipient of the Canada Gairdner Global Health Award, recognizing … Gairdners honour researcher who went from outsider to stem–cell pioneerThe Globe and Mail |
BioPharma-Reporter.com |
AstraZeneca buys into Harvard’s stem cell tech for diabetes R&D
FierceBiotech Harvard professor Doug Melton is having quite a week. His work on potential cell therapies for diabetes just fueled the launch of a well-funded biotech startup, and now he’s signed up with AstraZeneca ($AZN) to help the drugmaker spotlight new … AstraZeneca to Collaborate with the Harvard Stem Cell Institute in DiabetesPharmacy Times (registration) AstraZeneca and Harvard Team Up on Stem Cell Therapies for DiabetesGenetic Engineering & Biotechnology News AstraZeneca Inks Collaboration With Harvard Stem Cell InstituteLondon South East BioPharma-Reporter.com all 11 news articles » |